Head-to-head · Value Score
CoreAge Rx vs BetterMe Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, BetterMe Rx a 74. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameBetterMe Rx
#165 · Grade C+ · Watch List
Est. first month
$279/mo month-to-month, billed every 4 weeks ($205 first-order offer; $145/mo on 12 months)
Save ~79% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 74 — an est. $99/mo first month, with no teaser step-up baked in. BetterMe Rx isn't out of it: People who want a verified pharmacy and an oral option, and who are willing to commit to six or twelve months to bring the monthly figure down near the middle of the market.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | BetterMe Rx |
|---|---|---|
| Value Score | 93 (A+) | 74 (C+) |
| Est. first month | $99/mo | $279/mo month-to-month, billed every 4 weeks ($205 first-order offer; $145/mo on 12 months) |
| Save vs brand-name | ~89% | ~79% |
| Semaglutide | $99/mo | $279/mo month-to-month, billed every 4 weeks ($205 first-order offer; $145/mo on 12 months) |
| Tirzepatide | $149/mo | $379/mo month-to-month, billed every 4 weeks ($275 first-order offer) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
BetterMe Rx
Publishes no price at all until you finish the quiz, and what is behind it is dearer than the front page suggests: $279 a month for semaglutide, $379 for tirzepatide, each billed every four weeks rather than monthly.
Why it's a deal
- Carries LegitScript Certified, HIPAA Compliant and US Pharmacies badges on the page itself
- Sells oral semaglutide and oral tirzepatide as well as the injections, which the public page does not mention
- The whole plan ladder is shown at once once you are through - 1, 3, 6 and 12 months side by side, from $279 down to $145
- States that dose adjustments are included at no extra fee and that one price covers every dosage level
- Says it operates in all 50 states with US board-certified physicians and no insurance required
The fine print
- No price is published anywhere public - you must complete an eligibility quiz and hand over an email and phone number before seeing one
- A "month" is a four-week supply and the twelve-month plan is a 48-week supply, so a calendar year costs more than twelve times the monthly figure
- The public page advertises "$300 off your first order"; the funnel offers $154 off
- The plan page runs a countdown timer and a "only 39 discounts left" counter, which is pressure rather than information
- The lower rates need three, six or twelve months paid as a block - month to month is $279 and $379
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to BetterMe Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.